Asia stocks rise: Japan surges on Takaichi bets, China buoyed by positive GDP
Investing.com - Oppenheimer has reiterated an Outperform rating on salesforce.com (NYSE:CRM) with a price target of $315.00 following the company’s investor day. According to InvestingPro analysis, Salesforce appears undervalued at its current price of $236.58, with analyst targets ranging from $221 to $430.
The research firm expressed confidence in Salesforce’s medium-term guidance, which projects a 10% CAGR and 40% operating margin, indicating reaccelerating organic growth alongside margin expansion in the next 12-18 months. The company’s impressive gross profit margin of 77.65% and strong financial health score support this outlook.
Oppenheimer highlighted Salesforce’s AI innovation as a positive factor, noting new agentic product announcements, new pricing structures, and increasing referenceability in the market.
The firm also acknowledged Salesforce’s introduction of a new bookings metric designed to increase transparency for investors, though it observed that Agentforce deployments remain in early testing phases rather than scaled production.
Oppenheimer concluded that Salesforce maintains a strategic position to support agentic modernization across enterprise IT systems, with the firm citing increased confidence in the company’s innovation, AI monetization trends, and financial guidance as factors supporting higher multiples. Notably, Salesforce has achieved a perfect Piotroski Score of 9, reflecting strong operational efficiency and financial stability.
In other recent news, Salesforce has been the focus of several analyst reports following its Analyst Day and Dreamforce conference. BofA Securities reiterated its Buy rating with a $325 price target, noting that Salesforce’s topline growth target of over 10% CAGR through fiscal year 2030 aligns with market expectations. They also highlighted Salesforce’s "rule of 50" target, implying margins of about 40%, which suggests annual expansion that exceeds current forecasts. Wolfe Research maintained an Outperform rating with a $310 price target, emphasizing Salesforce’s confidence in achieving double-digit organic growth to reach over $60 billion in revenue by 2030.
KeyBanc reiterated its Overweight rating with a $400 price target, citing anticipated growth acceleration based on comments from Salesforce executives. Canaccord Genuity also maintained a Buy rating and a $300 price target, noting improvements in Salesforce’s platform and expanded commercial licensing options. Needham upheld its Buy rating with a $400 price target, pointing to significant investments in Salesforce applications by large language model vendors. These developments reflect a consistent positive outlook from various analysts on Salesforce’s growth and strategic initiatives.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.